Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.5 to v3.6.6, reflecting a version update to the page's underlying documentation or software. This indicates the content has been refreshed at the system level rather than adding new study information.
    Difference
    0.0%
    Check dated 2026-08-31T17:16:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a new revision label, v3.6.5, replacing the previous v3.6.4 to reflect a small backend or build update.
    Difference
    0.0%
    Check dated 2026-08-10T10:36:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This reflects a minor update to the page version with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-27T05:42:23.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small update to the page's software or documentation.
    Difference
    0.0%
    Check dated 2026-07-05T05:16:29.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page displays an updated revision tag, changing from v3.6.0 to v3.6.2, indicating an internal update to the page.
    Difference
    0.0%
    Check dated 2026-06-27T03:30:12.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated, replacing the old Intervention / Treatment and noting Revision: v3.5.5 with Revision: v3.6.0. A recruitment status update now states No longer looking for participants, indicating the study is no longer enrolling.
    Difference
    0.2%
    Check dated 2026-06-13T00:16:47.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.